5 Stocks Making Investors Richer

Page 1 of 5

In this article, we deep dive into the 5 stocks defying the market slump. For a deeper discussion and an extended list, please see 10 Stocks Making Investors Richer.

Photo by Mizuno K on Pexels

5. Moderna Inc. (NASDAQ:MRNA)

Moderna extended its winning streak to a fifth consecutive day on Wednesday, climbing 11.55 percent to end at $61.80 apiece, as investors loaded their portfolios ahead of its Investor Day.

In a notice, Moderna Inc. (NASDAQ:MRNA) said that it will host an Investor Event at 9 AM ET next Thursday, June 25.

The company said that it is set to discuss and feature research and early development programs, highlighting how its mRNA platform, together with advances in AI and robotics, is accelerating innovation and creating opportunities to expand into new therapeutic areas.

In other news, Moderna Inc. (NASDAQ:MRNA) on Tuesday said that it is anticipating the launch of three vaccines for flu plus COVID, seasonal flu, and norovirus over the next two years.

At the same time, it is expecting important clinical milestones this year, including potential pivotal data readouts for its investigational individualized neoantigen therapy (Intismeran autogene) and a therapeutic for the rare genetic disease propionic acidemia, which could support the possible launch of its first oncology and rare disease products.

In other news, Moderna Inc. (NASDAQ:MRNA) appointed Ester Banque as its new chief commercial officer, effective on Monday, June 15. She is tasked to focus on continuing to build out the company’s global commercial organization, leading execution across product launches, and expanding presence in new markets.

Page 1 of 5
1281292 - 11759070 - 1